• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    3/15/24 2:31:53 PM ET
    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Computer Software: Prepackaged Software
    Technology
    Computer Software: Programming Data Processing
    Technology
    Get the next $ADBE alert in real time by email

    Shares of Jabil Inc. (NYSE:JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

    Jabil posted adjusted earnings of $1.68 per share, beating estimates of $1.66 per share. The company’s quarterly sales came in at $6.77 billion, missing expectations of $6.89 billion.

    Jabil shares dipped 14.2% to $126.56 on Friday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Verb Technology Company, Inc. (NASDAQ:VERB) shares jumped 189% to $0.4047. VERB's MARKET.live launched Facebook and Instagram social shopping technology integration.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) surged 108% to $0.0728. Better Therapeutics recently said it will seek strategic alternatives and will be delisted from the Nasdaq.
    • Jet.AI Inc. (NASDAQ:JTAI) shares climbed 76.7% to $1.1950.
    • Cardlytics, Inc. (NASDAQ:CDLX) rose 57.1% to $12.86 after the company reported better-than-expected fourth-quarter earnings.
    • American Vanguard Corporation (NYSE:AVD) climbed 25.8% to $13.32 following fourth-quarter financial results.
    • Blend Labs, Inc. (NASDAQ:BLND) climbed 24.3% to $2.92 after the company reported fourth-quarter financial results.
    • HCM Acquisition Corp (NASDAQ:HCMA) gained 22.8% to $12.00.
    • Solidion Technology Inc. (NASDAQ:STI) rose 22.2% to $1.5897. The company announced the pricing of a $3.85 million private placement.
    • Tredegar Corporation (NYSE:TG) surged 18% to $4.73 following fourth-quarter financial results.
    • BranchOut Food Inc. (NASDAQ:BOF) rose 17.3% to $2.20. BranchOut Food will debut new products at Natural Products Expo West.
    • Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) rose 16.3% to $283.29 after the company announced FDA approval of Rezdiffra for the treatment of patients with noncirrhotic NASH with moderate to advanced liver fibrosis.
    • Secoo Holding Limited (NASDAQ:SECO) gained 16% to $0.5017.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) jumped 15.1% to $31.81. Roth MKM recently maintained a Buy rating on the stock and raised its price target from $12.50 to $27.50.
    • EHang Holdings Limited (NASDAQ:EH) jumped 14.3% to $15.56 after the company reported financial fourth-quarter results above estimates and issued first-quarter revenue guidance.
    • WW International, Inc. (NASDAQ:WW) gained 13% to $2.11.
    • CommScope Holding Company, Inc. (NASDAQ:COMM) rose 13% to $1.6502.
    • CS Disco, Inc. (NYSE:LAW) surged 11.9% to $7.71. CS Disco’s board approved a $20 million share repurchase authorization.
    • Alta Equipment Group Inc. (NYSE:ALTG) rose 10.7% to $11.64 following better-than-expected fourth-quarter 2023 results.
    • Despegar.com, Corp. (NYSE:DESP) gained 9.6% to $10.85 after the company reported mixed fourth-quarter 2023 results, with sales beating estimates.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares gained 7.2% to $5.63. Aquestive Therapeutics said Anaphylm met all predefined primary and secondary pharmacokinetic endpoints.
    • Fisker Inc. (NYSE:FSR) shares rose 6.7% to $0.1654. Fisker shares dipped around 52% on Thursday following a Wall Street Journal report suggesting the company is preparing for a possible bankruptcy filing.
    • The Buckle, Inc. (NYSE:BKE) gained 5.4% to $39.71 following fourth-quarter 2023 results.

    Losers

    • C3is Inc. (NASDAQ:CISS) shares fell 62.5% to $0.0296 after the company announced pricing of a $6 million underwritten public offering.
    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) fell 34.8% to $1.01. SELLAS Life Sciences Group announced a $20 million registered direct offering and concurrent private placement of 13,029316 shares each for combined purchase price of $1.535/share.
    • Immuneering Corporation (NASDAQ:IMRX) dipped 27% to $2.1150 after multiple analysts downgraded the stock following Thursday data from the company's Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in advanced RAS-mutant solid tumors.
    • Lucy Scientific Discovery Inc. (NASDAQ:LSDI) fell 25.6% to $1.25.
    • Xcel Brands, Inc. (NASDAQ:XELB) dipped 22.1% to $0.7630 after the company announced pricing of a $2.42 million public offering of common stock and concurrent private placement.
    • Altus Power, Inc. (NYSE:AMPS) declined 19.7% to $4.7650 after the company reported worse-than-expected quarterly financial results and issued FY24 revenue guidance below estimates.
    • Presto Automation Inc. (NASDAQ:PRST) fell 19.1% to $0.2438 after surging 34% on Thursday. The company announced the pricing of a $1.2 million registered direct offering of 4.8 million shares of common stock at $0.25 per share.
    • Babcock & Wilcox Enterprises, Inc. (NYSE:BW) dipped 19.1% to $1.0350 after the company reported worse-than-expected quarterly financial results.
    • Biofrontera Inc. (NASDAQ:BFRI) declined 18.3% to $1.43.
    • Groupon, Inc. (NASDAQ:GRPN) fell 17.8% to $14.91 after the company reported fourth-quarter financial results.
    • EverCommerce Inc. (NASDAQ:EVCM) fell 17.3% to $7.74 following weak quarterly results.
    • Psyence Biomedical Ltd. (NASDAQ:PBM) fell 14.3% to $1.3627. Psyence Biomedical shares jumped 53% on Thursday after the Indiana legislature sent a bill that includes funding for psilocybin clinical research trials to the governor.
    • Adobe Inc. (NASDAQ:ADBE) dipped 13.3% to $494.25. Adobe reported better-than-expected results for its first quarter but issued weak revenue guidance for the current quarter.
    • Blink Charging Co. (NASDAQ:BLNK) shares fell 11.8% to $3.0250 following fourth-quarter financial results.
    • Montauk Renewables, Inc. (NASDAQ:MNTK) tumbled 10.8% to $4.54 following weak quarterly results.
    • Kopin Corporation (NASDAQ:KOPN) fell 10.3% to $1.9650 after reporting weaker-than-expected fourth-quarter results.
    • AdTheorent Holding Company, Inc. (NASDAQ:ADTH) dipped 10% to $3.35.
    • PagerDuty, Inc. (NYSE:PD) shares fell 9.7% to $20.70 after the company reported fourth-quarter financial results and issued FY25 guidance below estimates.
    • Soho House & Co Inc. (NYSE:SHCO) declined 9.7% to $5.19 following downbeat fourth-quarter financial results.
    • Zillow Group, Inc. (NASDAQ:Z) dipped 8.3% to $50.55.
    • Ulta Beauty, Inc. (NASDAQ:ULTA) shares tumbled 6.5% to $528.96 after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. The company's board of directors approved a new share repurchase authorization of $2.0 billion.
    • Sanmina Corporation (NASDAQ:SANM) dipped 5.8% to $59.45.
    • Smartsheet Inc. (NASDAQ:SMAR) fell 4.3% to $38.57 after the company reported fourth-quarter financial results and issued FY25 revenue guidance below estimates.
    • MicroStrategy Incorporated (NASDAQ:MSTR) shares fell 3% to $1,627.26. MicroStrategy shares fell 5% on Thursday after the company announced a proposed private offering of $500 million of convertible senior notes due 2031.

     

    Now Read This: Ethereum Falls Below $3,700; Bitcoin SV, Injective Among Top Losers

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ADTH
    $ALTG
    $AMPS

    CompanyDatePrice TargetRatingAnalyst
    Ulta Beauty Inc.
    $ULTA
    2/20/2026$647.00 → $800.00Strong Buy
    Raymond James
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Madrigal Pharmaceuticals Inc.
    $MDGL
    1/28/2026$964.00Overweight
    Barclays
    Strategy Inc
    $MSTR
    1/27/2026$213.00Overweight
    Cantor Fitzgerald
    Babcock & Wilcox Enterprises Inc.
    $BW
    1/22/2026$10.00Outperform
    Northland Capital
    Ulta Beauty Inc.
    $ULTA
    1/21/2026$790.00Outperform → Strong Buy
    Raymond James
    Ulta Beauty Inc.
    $ULTA
    1/14/2026$700.00Hold
    Jefferies
    Adobe Inc.
    $ADBE
    1/13/2026Outperform → Perform
    Oppenheimer
    More analyst ratings

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Offerdahl James bought $11,970 worth of shares (3,000 units at $3.99), increasing direct ownership by 1% to 223,652 units (SEC Form 4)

    4 - CS Disco, Inc. (0001625641) (Issuer)

    2/11/26 5:11:47 PM ET
    $LAW
    Computer Software: Prepackaged Software
    Technology

    Director Loparco Michael J bought $99,722 worth of shares (700 units at $142.46), increasing direct ownership by 28% to 3,196 units (SEC Form 4)

    4 - SANMINA CORP (0000897723) (Issuer)

    2/3/26 4:01:12 PM ET
    $SANM
    Electrical Products
    Technology

    Director Popstefanov Gjorgi bought $99,999,999 worth of shares (11,111,111 units at $9.00) (SEC Form 4)

    4 - Soho House & Co Inc. (0001846510) (Issuer)

    2/2/26 6:59:52 PM ET
    $SHCO
    Hotels/Resorts
    Consumer Discretionary

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    SEC Filings

    View All

    Biofrontera Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Biofrontera Inc. (0001858685) (Filer)

    2/26/26 9:20:29 AM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aquestive Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)

    2/26/26 8:07:14 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by C3is Inc.

    424B3 - C3is Inc. (0001951067) (Filer)

    2/25/26 4:37:57 PM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma's Patent 11,697,028 To Be Unpatentable

    WOBURN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization and development of photodynamic therapy ("PDT"), today announced that on February 23, 2026, the U.S. Patent Trial and Appeal Board (the "Board") issued a Final Written Decision finding all challenged claims of Sun Pharmaceutical Industries, Inc.'s U.S. Patent No. 11,697,028 (the "'028 Patent") to be unpatentable. As previously disclosed in Biofrontera's filings with the Securities and Exchange Commission, in June 2024, Sun Pharma initiated proceedings against Biofrontera and certain of its affiliates in the U.S. District Court for the District

    2/26/26 9:15:00 AM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Orange 142 Expands Visit El Paso's Reach Through Targeted Digital Campaign

    Multi-channel strategy delivers more than 3.6 million impressions across top U.S. markets AUSTIN, Texas, Feb. 26, 2026 /PRNewswire/ -- Orange 142, LLC ("Orange 142"), a division of Direct Digital Holdings (NASDAQ:DRCT), and a leading digital marketing agency for mid-market brands and agencies, executed a targeted digital advertising campaign in partnership with Visit El Paso to reach meeting planners in highly competitive U.S. markets where destinations compete for meetings and events.As meeting planners evaluated destinations nationwide, Visit El Paso sought to increase visibility in competitive markets and strengthen consideration among planners assessing options for future events. Orange

    2/26/26 9:00:00 AM ET
    $DRCT
    Advertising
    Consumer Discretionary

    Kopin Secures $3.6 Million Order for New Advanced Avionic Helmet‑Mounted Display System for European Military Aircraft Platform

    Kopin Corporation (NASDAQ:KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced it has secured a new $3.6 million purchase order for an advanced avionic helmet‑mounted display ("HMD") system to be integrated into a rotary‑wing military aircraft platform for a European defense customer. The HMD system will serve as a critical component of the aircraft's pilot interface, delivering flight symbology, navigation cues, aircraft status, and weapon‑system information directly into the pilot's line of sight. By projecting essential data onto a high‑brightness

    2/26/26 8:31:00 AM ET
    $KOPN
    Semiconductors
    Technology

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James reiterated coverage on Ulta Beauty with a new price target

    Raymond James reiterated coverage of Ulta Beauty with a rating of Strong Buy and set a new price target of $800.00 from $647.00 previously

    2/20/26 10:41:08 AM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    Adobe downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Adobe from Overweight to Neutral and set a new price target of $330.00

    2/3/26 6:51:31 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    Barclays initiated coverage on Madrigal Pharmaceuticals with a new price target

    Barclays initiated coverage of Madrigal Pharmaceuticals with a rating of Overweight and set a new price target of $964.00

    1/28/26 7:18:07 AM ET
    $MDGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for REZDIFFRA issued to MADRIGAL PHARMACEUTICALS INC

    Submission status for MADRIGAL PHARMACEUTICALS INC's drug REZDIFFRA (ORIG-1) with active ingredient RESMETIROM has changed to 'Approval' on 03/14/2024. Application Category: NDA, Application Number: 217785, Application Classification: Type 1 - New Molecular Entity

    3/14/24 3:35:50 PM ET
    $MDGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CFO Faust Jonathan P sold $1,604,948 worth of shares (10,075 units at $159.30), decreasing direct ownership by 10% to 87,076 units (SEC Form 4)

    4 - SANMINA CORP (0000897723) (Issuer)

    2/25/26 5:30:33 PM ET
    $SANM
    Electrical Products
    Technology

    Director Hedley David V Iii sold $166,205 worth of shares (1,024 units at $162.31), decreasing direct ownership by 14% to 6,340 units (SEC Form 4)

    4 - SANMINA CORP (0000897723) (Issuer)

    2/25/26 5:28:25 PM ET
    $SANM
    Electrical Products
    Technology

    Chief Executive Officer Remer Eric Richard sold $120,904 worth of shares (11,490 units at $10.52), decreasing direct ownership by 0.44% to 2,615,886 units (SEC Form 4)

    4 - EverCommerce Inc. (0001853145) (Issuer)

    2/25/26 5:14:05 PM ET
    $EVCM
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Leadership Updates

    Live Leadership Updates

    View All

    Bonnell Aluminum Announces New Vice President of Sales and Marketing

    Bonnell Aluminum, a subsidiary of Tredegar Corporation (NYSE:TG), is pleased to announce the appointment of Tracy Bridges to the position of Vice President of Sales and Marketing, effective March 1, 2026. She will be replacing Eric Yost, who will be retiring from the Company after 28 years of service. Ms. Bridges has been with Bonnell Aluminum for more than 20 years, serving most recently as Director of Customer Experience. Her previous roles in the organization have included Regional Sales Manager, Segment Sales Manager, and Market Manager. Brook Hamilton, President of Bonnell Aluminum, said, "We thought it was very important to identify a successor who will give our business and custo

    2/25/26 8:30:00 AM ET
    $TG
    Metal Fabrications
    Industrials

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the voting results from its Annual and Special Meeting of Shareholders (the "Meeting"), held at 9:00 a.m. Eastern Time on February 12, 2026. Shareholders voted in favour of all matters of business presented at the Meeting, including the election of directors, the appointment of auditors and the approval of share consolidation authority for the board of directors (the "Board"). All director nominees listed in the Company's management informat

    2/17/26 9:15:00 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Financials

    Live finance-specific insights

    View All

    DISCO Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenue of $41.2 Million, A Year over Year Increase of 11% CS Disco, Inc. ("DISCO") (NYSE:LAW) today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "DISCO continues to show what's possible as an innovator in legal technology as our AI solutions were significant growth drivers in the fourth quarter and a key part of strong full-year results for 2025," said Eric Friedrichsen, CEO of DISCO. "We are continuing that disruptive trend in 2026 with the launch of the industry's first scaled agentic AI solution for eDiscovery and a new AI-inclusive platform that combines all of our Cecilia AI platform capabilities into a singl

    2/25/26 7:30:00 AM ET
    $LAW
    Computer Software: Prepackaged Software
    Technology

    Groupon Announces Date for Fourth Quarter and Full Year 2025 Financial Results

    Chicago, Illinois--(Newsfile Corp. - February 25, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's fourth quarter and full year 2025 financial results after the market closes on Tuesday, March 10, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Wednesday, March 11, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NAS

    2/25/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET

    WARREN, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the fourth quarter ended December 31, 2025 and provide an update on recent developments in its business after market close on Wednesday, March 4, 2026. Management will host a conference call for investors at 8:00 a.m. ET on Thursday, March 5, 2026. To participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webc

    2/24/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADTH
    $ALTG
    $AMPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form SC 13G filed by Psyence Biomedical Ltd.

    SC 13G - PSYENCE BIOMEDICAL LTD. (0001985062) (Subject)

    12/13/24 9:16:01 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BranchOut Food Inc.

    SC 13D/A - BranchOut Food Inc. (0001962481) (Subject)

    12/11/24 5:14:42 PM ET
    $BOF
    Packaged Foods
    Consumer Staples